PTRN · Pattern Group Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on PTRN. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About PTRN · Pattern Group Inc.
Pattern Group Inc. operates as an e-commerce accelerator that combines proprietary technology and on-demand expertise to support consumer brands operating across e-commerce marketplaces in the United States and internationally. The company acquires inventory from brand partners to sell to consumers in various industries, including health and wellness; beauty and personal care; home and lifestyle; pet; sports and outdoors; and consumer electronics. The company was formerly known as Covalent Group, Inc. and changed its name to Pattern Group Inc. in November 2024. Pattern Group Inc. was incorporated in 2018 and is headquartered in Lehi, Utah.
Live Quote
HOLD (score +1) · 12-1 mom 12.7% · RSI 65.8 · above_50_only · 0.0% from high
Targets blend Wall Street consensus (9 analysts: low $19.00 / mean $22.44 / high $26.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Pattern Group is a $3.5B market cap e-commerce accelerator that just completed its first full year as a public company (IPO September 2025). Q1 2026 results were record-breaking ($774M revenue, +43% YoY; net income of $29.2M; NRR of 127%). The stock has surged ~57% over the past 90 days to new highs near $17-18. However, the investigation trigger — three Form 4 filings in 14 days with an open-market P/S trade verified — did NOT hold up under scrutiny: all three May 2026 filings were RSU grants (code A at $0) to non-employee directors, not open-market purchases. The September 2025 cluster was entirely IPO-reclassification and selling (Daniel Gay sold ~$17M at the Offering price of $13.02). No CEO or CFO open-market purchase exists in the dataset. The company has excellent fundamentals but is fully valued on EV/EBITDA (~48x) with an overbought RSI (72), elevated IV (74-83%), and no genuine insider buying signal to support a long thesis.